EDP Sciences logo
Authentification abonné
Rechercher
Menu
Accueil Tous les numéros Volume 41 / Numéro 4 (Avril 2025) Med Sci (Paris), 41 4 (2025) 346-354 Références
Open Access
Numéro
Med Sci (Paris)
Volume 41, Numéro 4, Avril 2025
Page(s) 346 - 354
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2025047
Publié en ligne 28 avril 2025
  1. Ankavay M, Dubuisson J, Cocquerel L. Le virus de l’hépatite E: Un virus méconnu qui se dévoile. Med Sci (Paris) 2018 ; 34 : 1071–78. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Lhomme S, Marion O, Abravanel F, et al. Clinical manifestations, pathogenesis and treatment of hepatitis E virus infections. J Clin Med 2020 ; 9 : 331. [CrossRef] [PubMed] [Google Scholar]
  3. Kamar N, Selves J, Mansuy J-M, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008 ; 358 : 811–17. [CrossRef] [PubMed] [Google Scholar]
  4. Pallerla SR, Harms D, Johne R, et al. Hepatitis E virus infection: circulation, molecular epidemiology, and impact on global health. Pathogens 2020 ; 9 : 856. [CrossRef] [PubMed] [Google Scholar]
  5. Khuroo MS. Hepatitis E and Pregnancy: An Unholy Alliance Unmasked from Kashmir, India. Viruses 2021 ; 13 : 1329. [CrossRef] [PubMed] [Google Scholar]
  6. Pavio N, Kooh P, Cadavez V, et al. Risk factors for sporadic hepatitis E infection: a systematic review and meta-analysis. Microb Risk Anal 2021 ; 17 : 100129. [Google Scholar]
  7. WHO. Hepatitis E - Fact sheets. 2023. [Google Scholar]
  8. Kang S, Chung E, Hong C, et al. Raising the case of hepatitis E: Report from the 2nd international HEV symposium. Vaccine 2024 ; 42 : 126398. [CrossRef] [PubMed] [Google Scholar]
  9. Li P, Liu J, Li Y, et al. The global epidemiology of hepatitis E virus infection: A systematic review and meta–analysis. Liver Int 2020 ; 40 : 1516–28. [CrossRef] [PubMed] [Google Scholar]
  10. Mansuy JM, Gallian P, Dimeglio C, et al. A nationwide survey of hepatitis E viral infection in French blood donors. Hepatology 2016 ; 63 : 1145–54. [CrossRef] [PubMed] [Google Scholar]
  11. Aspinall EJ, Couturier E, Faber M, et al. Hepatitis E virus infection in Europe: surveillance and descriptive epidemiology of confirmed cases, 2005 to 2015. Euro Surveill 2017 ; 22. [Google Scholar]
  12. Pavio N, Merbah T, Thébault A. Frequent hepatitis E virus contamination in food containing raw pork liver, France. Emerg Infect Dis 2014 ; 20 : 1925–27. [CrossRef] [PubMed] [Google Scholar]
  13. Lhomme S, Magne S, Perelle S, et al. Clustered Cases of Waterborne Hepatitis E Virus Infection, France. Viruses 2023 ; 15 : 1149. [CrossRef] [PubMed] [Google Scholar]
  14. Fenaux H, Chassaing M, Berger S, et al. Transmission of hepatitis E virus by water: An issue still pending in industrialized countries. Water Research 2019 ; 151 : 144–57. [CrossRef] [PubMed] [Google Scholar]
  15. Treagus S, Lowther J, Longdon B, et al. Metabarcoding of hepatitis e virus genotype 3 and norovirus gii from wastewater samples in england using nanopore sequencing. Food Environ Virol 2023 ; 15 : 292–306. [CrossRef] [PubMed] [Google Scholar]
  16. Pillonel J, Maugard C, Sommen C, et al. Risk of a blood donation contaminated with hepatitis E virus entering the blood supply before the implementation of universal RNA screening in France. Vox Sang 2022 ; 117 : 1411–14. [CrossRef] [PubMed] [Google Scholar]
  17. Casares-Jimenez M, Garcia-Garcia T, Suárez-Cárdenas JM, et al. Correlation of hepatitis E and rat hepatitis E viruses urban wastewater monitoring and clinical cases. Sci Total Environ 2024 ; 908 : 168203. [CrossRef] [PubMed] [Google Scholar]
  18. Sridhar S, Situ J, Cai J-P, et al. Multimodal investigation of rat hepatitis E virus antigenicity: Implications for infection, diagnostics, and vaccine efficacy. J Hepatol 2021 ; 74 : 1315–24. [CrossRef] [PubMed] [Google Scholar]
  19. Devhare PB, Desai S, Lole KS. Innate immune responses in human hepatocyte-derived cell lines alter genotype 1 hepatitis E virus replication efficiencies. Sci Rep 2016 ; 6 : 26827. [CrossRef] [PubMed] [Google Scholar]
  20. Lhomme S, Migueres M, Abravanel F, et al. Hepatitis E Virus: How It Escapes Host Innate Immunity. Vaccines 2020 ; 8 : 422. [CrossRef] [PubMed] [Google Scholar]
  21. Yin X, Li X, Ambardekar C, et al. Hepatitis E virus persists in the presence of a type III interferon response. PLoS Pathog 2017 ; 13 : e1006417. [CrossRef] [PubMed] [Google Scholar]
  22. Murata K, Kang J-H, Nagashima S, et al. IFN-λ3 as a host immune response in acute hepatitis E virus infection. Cytokine 2020 ; 125 : 154816. [CrossRef] [PubMed] [Google Scholar]
  23. Meyer L, Duquénois I, Gellenoncourt S, et al. Identification of interferon- stimulated genes with modulated expression during hepatitis E virus infection in pig liver tissues and human HepaRG cells. Front Immunol 2023 ; 14 : 1291186. [CrossRef] [PubMed] [Google Scholar]
  24. León-Janampa N, Caballero-Posadas I, Barc C, et al. A pig model of chronic hepatitis E displaying persistent viremia and a downregulation of innate immune responses in the liver. Hepatol Commun 2023 ; 7 : e0274. [PubMed] [Google Scholar]
  25. Moal V, Textoris J, Ben Amara A, et al. Chronic hepatitis E virus infection is specifically associated with an interferon-related transcriptional program. J Infect Dis 2013 ; 207 : 125–32. [CrossRef] [PubMed] [Google Scholar]
  26. Pingale KD, Kanade GD, Karpe YA. Hepatitis E virus polymerase binds to IFIT1 to protect the viral RNA from IFIT1-mediated translation inhibition. J Gen Virol 2019 ; 100 : 471–83. [CrossRef] [PubMed] [Google Scholar]
  27. Xu L, Wang W, Li Y, et al. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production: Xu et al. Hepatology 2017 ; 65 : 1823–39. [CrossRef] [PubMed] [Google Scholar]
  28. Plümers R, Dreier J, Knabbe C, et al. Kinetics of hepatitis E virus infections in asymptomatic persons. Emerg Infect Dis 2024 ; 30. [Google Scholar]
  29. Huang S, Zhang X, Su Y, et al. Long-term efficacy of a recombinant hepatitis E vaccine in adults: 10-year results from a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet 2024 ; 403 : 813–23. [CrossRef] [PubMed] [Google Scholar]
  30. Kulkarni SP, Sharma M, Tripathy AS. Antibody and memory B cell responses in hepatitis E recovered individuals, 1-30 years post hepatitis E virus infection. Sci Rep 2019 ; 9 : 4090. [CrossRef] [PubMed] [Google Scholar]
  31. Zhang J, Zhang X-F, Zhou C, et al. Protection against hepatitis E virus infection by naturally acquired and vaccine-induced immunity. Clin Microbiol Infect 2014 ; 20 : 397–405. [Google Scholar]
  32. Brüggemann Y, Klöhn M, Todt D. The pivotal role of CD8+ T cells in hepatitis E virus infection. J Hepatol 2022 ; 77 : 909–11. [CrossRef] [PubMed] [Google Scholar]
  33. León-Janampa N, Boennec N, Le Tilly O, et al. Relevance of tacrolimus trough concentration and hepatitis E virus genetic changes in kidney transplant recipients with chronic hepatitis E. Kidney Int Rep 2024 ; 9 : 1333–42. [CrossRef] [PubMed] [Google Scholar]
  34. Kamar N, Garrouste C, Haagsma EB, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011 ; 140 : 1481–89. [CrossRef] [PubMed] [Google Scholar]
  35. Kumar A, Saraswat VA. Hepatitis E and acute-on-chronic liver failure. J Clin Exp Hepatol 2013 ; 3 : 225–30. [CrossRef] [PubMed] [Google Scholar]
  36. Wu J, Xiang Z, Zhu C, et al. Extrahepatic manifestations related to hepatitis E virus infection and their triggering mechanisms. J Infect 2021 ; 83 : 298–305. [CrossRef] [PubMed] [Google Scholar]
  37. Marion O, Lhomme S, Nayrac M, et al. Hepatitis E virus replication in human intestinal cells. Gut 2020 ; 69 : 901–10. [CrossRef] [PubMed] [Google Scholar]
  38. Ying D, He Q, Tian W, et al. Urine is a viral antigen reservoir in hepatitis E virus infection. Hepatology 2023 ; 77 : 1722. [CrossRef] [PubMed] [Google Scholar]
  39. Tian D, Li W, Heffron CL, et al. Hepatitis E virus infects brain microvascular endothelial cells, crosses the blood-brain barrier, and invades the central nervous system. Proc Natl Acad Sci U S A 2022 ; 119 : e2201862119. [CrossRef] [PubMed] [Google Scholar]
  40. Bose PD, Das BC, Hazam RK, et al. Evidence of extrahepatic replication of hepatitis E virus in human placenta. J Gen Virol 2014 ; 95 : 1266–71. [CrossRef] [PubMed] [Google Scholar]
  41. Geng Y, Zhao C, Huang W, et al. Detection and assessment of infectivity of hepatitis E virus in urine. J Hepatol 2016 ; 64 : 37–43. [CrossRef] [PubMed] [Google Scholar]
  42. Dalton HR, Kamar N, Baylis SA, et al. EASL Clinical practice guidelines on hepatitis E virus infection. J Hepatol 2018 ; 68 : 1256–71. [CrossRef] [PubMed] [Google Scholar]
  43. Gouilly J, Chen Q, Siewiera J, et al. Genotype specific pathogenicity of hepatitis E virus at the human maternal-fetal interface. Nat Commun 2018 ; 9 : 4748. [CrossRef] [PubMed] [Google Scholar]
  44. Yadav KK, Boley PA, Fritts Z, et al. Ectopic expression of genotype 1 hepatitis E virus ORF4 increases genotype 3 HEV viral replication in cell culture. Viruses 2021 ; 13 : 75. [CrossRef] [PubMed] [Google Scholar]
  45. Abravanel F, Pique J, Couturier E, et al. Acute hepatitis E in French patients and neurological manifestations. J Infect 2018 ; 77 : 220–26. [CrossRef] [PubMed] [Google Scholar]
  46. Schmitz J, Kracht J, Evert K, et al. Hepatitis E virus infection of transplanted kidneys. Am J Transplant 2024 ; 24 : 491–97. [CrossRef] [PubMed] [Google Scholar]
  47. Panic N, Mihajlovic S, Vujasinovic M, et al. Pancreatitis Associated with Viral Hepatitis: Systematic Review. J Clin Med 2020 ; 9 : 3309. [CrossRef] [PubMed] [Google Scholar]
  48. Rasizadeh R, Ebrahimi F, Zamani Kermanshahi A, et al. Viruses and thrombocytopenia. Heliyon 2024 ; 10 : e27844. [CrossRef] [PubMed] [Google Scholar]
  49. French Agency for Food, Environmental and Occupational Health & Safety. AVIS de l’Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail. n.d. [Google Scholar]
  50. WHO, Environment, Climate Change and Health (ECH), Water, Sanitation, Hygiene and Health (WSH). State of the world’s drinking water: An urgent call to action to accelerate progress on ensuring safe drinking water for all. 2022 : p. [Google Scholar]
  51. Li SW, Zhang J, Li YM, et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005 ; 23 : 2893–01. [CrossRef] [PubMed] [Google Scholar]
  52. Zhu F-C, Zhang J, Zhang X-F, et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large-scale, randomised, double-blind placebo-controlled, phase 3 trial. Lancet 2010 ; 376 : 895–902. [CrossRef] [PubMed] [Google Scholar]
  53. Zhang J, Zhang X-F, Huang S-J, et al. Long-term efficacy of a hepatitis E vaccine. N Engl J Med 2015 ; 372 : 914–22. [CrossRef] [PubMed] [Google Scholar]
  54. Zaman K, Julin CH, Aziz AB, et al. Safety and effectiveness of a recombinant hepatitis E vaccine in women of childbearing age in rural Bangladesh: a phase 4, double-blind, cluster-randomised, controlled trial. Lancet Glob Health 2024 ; 12 : e1288–99. [CrossRef] [PubMed] [Google Scholar]
  55. Nesbitt RC, Asilaza VK, Gignoux E, et al. Vaccination coverage and adverse events following a reactive vaccination campaign against hepatitis E in Bentiu displaced persons camp, South Sudan. PLoS Negl Trop Dis 2024 ; 18 : e0011661. [CrossRef] [PubMed] [Google Scholar]
  56. Aziz AB, Dudman S, Julin CH, et al. Receipt of hepatitis E vaccine and fetal loss in rural Bangladesh: further analysis of a double-blind, cluster- randomised, controlled trial. Lancet Glob Health 2024 ; 12 : e1300–11. [CrossRef] [PubMed] [Google Scholar]
  57. Nesbitt RC, Azman AS, Asilaza VK, et al. Safety of hepatitis E vaccine in pregnancy: an emulated target trial following a mass reactive vaccination campaign in Bentiu internally displaced persons camp, South Sudan. Lancet Glob Health 2024 ; 12 : e1881–90. [CrossRef] [PubMed] [Google Scholar]
  58. Lynch JA, Lim JK, Asaga PEP, et al. Hepatitis E vaccine—Illuminating the barriers to use. PLoS Negl Trop Dis 2023 ; 17 : e0010969. [CrossRef] [PubMed] [Google Scholar]
  59. WHO Immunization, Vaccines and Biologicals (IVB) team. WHO position paper on hepatitis E vaccines - May 2015. [Google Scholar]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.